Expanded Market Access Cibus has recently achieved political agreement on new genomic techniques legislation in Europe, supporting the introduction of gene-edited plant traits. This creates a significant opportunity for sales teams to target European seed companies and agricultural businesses seeking to leverage latest biotech innovations in their crop development portfolios.

Strategic Collaborations The company's partnership with AgVayā to introduce advanced gene editing solutions to Indian rice growers indicates a strong focus on emerging markets. Sales teams can explore opportunities to promote compatible traits and licensing deals with local seed companies and agribusinesses in India and other similar regions interested in sustainable crop productivity.

Crop Trait Expansion Cibus has developed and tested high-performance traits such as HT2 in canola and biofragrance products, with commercialization ambitions in 2026. This opens doors for sales efforts toward seed companies and agribusinesses looking to incorporate innovative traits that enhance yield, disease resistance, and crop quality.

Financial Growth Potential Despite recent quarterly losses, Cibus is focused on reducing cash usage and scaling its commercial activities. Sales strategies should target seed companies and international markets demonstrating appetite for licensed traits, especially as field trial success and product launches are imminent in 2025 and beyond.

Industry Positioning As a biotech innovator with strategic appointments to support global expansion, Cibus is positioning itself as a key supplier of gene-edited traits to seed developers worldwide. Business development efforts can focus on establishing licensing and partnership agreements with seed companies seeking cutting-edge biotech solutions to differentiate their product offerings.